Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Toxicology and Applied Pharmacology
|
March 2, 2019
Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primates
Christopher Geven, Matthijs Kox, Alice Blet, et al.
International Archives of Allergy and Immunology
|
November 21, 2024
Exploring the Landscape of Perioperative Immediate Hypersensitivity: A Comprehensive 6-Year Monocentric Observational Analysis on Epidemiology and Risk Factors
Arthur Moreau, Ményssa Chérifa, Eric Roland, et al.
British Journal of Clinical Pharmacology
|
June 2, 2018
Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects
Christopher Geven, Dirk van Lier, Alice Blet, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
|
December 26, 2021
The association of biological sex and long-term outcomes in patients with acute dyspnea at the emergency department
Prabakar Vaittinada Ayar, Justina Motiejūnaitė, Kamilė Čerlinskaitė, et al.
Scientific Reports
|
May 27, 2026
Effects of septic shock vasopressors on the fitness of Escherichia coli
Prabakar Vaittinada Ayar, Antoine Bridier-Nahmias, Pradeebane Vaittinada Ayar, et al.
BMJ Open
|
February 21, 2019
A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)
Christopher Geven, Alice Blet, Matthijs Kox, et al.
British Journal of Anaesthesia
|
December 13, 2021
High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort
Benjamin Deniau, Adrien Picod, Dirk Van Lier, et al.
Intensive Care Medicine Experimental
|
May 17, 2019
Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats
Alice Blet, Benjamin Deniau, Christopher Geven, et al.
Anaesthesia, Critical Care & Pain Medicine
|
December 14, 2020
A communication strategy based on Twitter improves article citation rate and impact factor of medical journals
Thomas Clavier, Emmanuel Besnier, Alice Blet, et al.
European Journal of Heart Failure
|
September 1, 2019
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
Koji Takagi, Alice Blet, Bruno Levy, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Toxicology and Applied Pharmacology
|
March 2, 2019
Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primates
Christopher Geven, Matthijs Kox, Alice Blet, et al.
International Archives of Allergy and Immunology
|
November 21, 2024
Exploring the Landscape of Perioperative Immediate Hypersensitivity: A Comprehensive 6-Year Monocentric Observational Analysis on Epidemiology and Risk Factors
Arthur Moreau, Ményssa Chérifa, Eric Roland, et al.
British Journal of Clinical Pharmacology
|
June 2, 2018
Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects
Christopher Geven, Dirk van Lier, Alice Blet, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
|
December 26, 2021
The association of biological sex and long-term outcomes in patients with acute dyspnea at the emergency department
Prabakar Vaittinada Ayar, Justina Motiejūnaitė, Kamilė Čerlinskaitė, et al.
Scientific Reports
|
May 27, 2026
Effects of septic shock vasopressors on the fitness of Escherichia coli
Prabakar Vaittinada Ayar, Antoine Bridier-Nahmias, Pradeebane Vaittinada Ayar, et al.
BMJ Open
|
February 21, 2019
A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)
Christopher Geven, Alice Blet, Matthijs Kox, et al.
British Journal of Anaesthesia
|
December 13, 2021
High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort
Benjamin Deniau, Adrien Picod, Dirk Van Lier, et al.
Intensive Care Medicine Experimental
|
May 17, 2019
Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats
Alice Blet, Benjamin Deniau, Christopher Geven, et al.
Anaesthesia, Critical Care & Pain Medicine
|
December 14, 2020
A communication strategy based on Twitter improves article citation rate and impact factor of medical journals
Thomas Clavier, Emmanuel Besnier, Alice Blet, et al.
European Journal of Heart Failure
|
September 1, 2019
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
Koji Takagi, Alice Blet, Bruno Levy, et al.
Page
of 7